Home / News / Research

Research

Impact of Childhood and Congenital DM on Quality of Life

Nicholas Johnson, MD, and researchers at the University of Rochester recently published an article in The Journal of Child Neurology that describes the impact of childhood and congenital myotonic dystrophy on quality of life.

A New Study Provides Hope for DM Treatments

Maurice Swanson, Ph.D., Professor of Molecular Genetics and Microbiology at University of Florida, Gainesville, and a team of researchers have found that the muscleblind-like 2 (MBNL2) protein in the central nervous system (CNS) may be responsible for the neurological impacts of myotonic dystrophy

Stanford's New DM Center Focuses on Care & Research

We recently talked about the development of Stanford's new Center for DM Care and Research with Dr. John Day, Professor of Neurology and & Neurological Sciences and Director of the Division of Neuromuscular Medicine and Neuromuscular Clinics at Stanford University.

Ritalin Could Curb Excessive Daytime Sleepiness

Methylphenidate, a psycho-stimulant drug, also known by its 1948 trademarked name of Ritalin, could be useful in the treatment of excessive daytime sleepiness (EDS) for DM1 patients, according to a recent study conducted by The Department of Human Genetics at the Centre Hospitalier Universitaire de Quebec in Quebec City, Canada.

MDF Awards $200,000 for Research into Treatments for DM

The Myotonic Dystrophy Foundation (MDF) is pleased to announce its most recent round of Fund-A-Fellow postdoctoral fellowship research grant awards. In January 2013, MDF awarded two $100,000 grants to postdoctoral Fellows working in universities and research facilities

Mexiletine for Myotonia: A New Use for an Old Heart Drug?

A generic cardiovascular drug called mexiletine, initially developed to treat heart rhythm abnormalities, appears to hold some potential for treating muscle stiffness and other symptoms of non-dystrophic myotonias (NDMs),

Antisense Oligonucleotides Make Sense in Myotonic Dystrophy

Antisense oligonucleotides – short segments of genetic material designed to target specific areas of a gene

Scientists Create Potent Molecules Aimed at Treating Myotonic Dystrophy

The new approach could have implications for many genetic diseases.

MDF Awards $400,000 for Research into Treatments for Myotonic Dystrophy

ROSEVILLE, CA (January 25, 2012): The Myotonic Dystrophy Foundation (MDF) is pleased to announce its largest-ever round of Fund-A-Fellow postdoctoral fellowship research grant awards.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.